581-72-6

Usage

Uses

Used in Chemical Research:
2-(BromoMethyl)-6-fluoronaphthalene is used as a research chemical for studying the properties and reactions of halogenated aromatic hydrocarbons. Its unique structure allows scientists to explore various chemical transformations and interactions, contributing to the advancement of organic chemistry.
Used in Synthesis of Other Compounds:
Due to its reactive functional groups, 2-(BromoMethyl)-6-fluoronaphthalene can be used as a starting material or intermediate in the synthesis of other organic compounds. Its bromomethyl group can undergo substitution reactions, while the fluoro substituent can participate in various chemical processes, making it a versatile building block in organic synthesis.
Used in Material Science:
Although not widely utilized in industrial applications, 2-(BromoMethyl)-6-fluoronaphthalene may have potential uses in material science, such as in the development of new polymers or materials with specific properties. Its halogenated nature could contribute to the creation of materials with altered physical or chemical characteristics.
Safety Precautions:
It is crucial to handle 2-(BromoMethyl)-6-fluoronaphthalene with care due to its potential hazards, including flammability and toxicity. Proper safety precautions should be followed when working with this chemical, such as using appropriate protective equipment and ensuring the work area is well-ventilated.

Upstream product

• 5043-01-6 6-fluoro-2-naphthoic acid 
• 944351-48-8 (6-fluoronaphthalen-2-yl)methanol 
• 29419-14-5 6-fluoro-2-tetralone 
• 324-42-5 2-fluoro-6-methylnaphthalene 
• 7726-95-6 bromine 
• 459-04-1 4-Fluorophenylacetyl chloride 
• 405-50-5 p-Fluorophenylacetic acid 

Downstream Products

• 1409968-56-4 C₃₀H₂₇FN₂O₂ 
• 1409968-55-3 C₂₇H₂₉FN₂O 
• 66922-61-0 (6-fluoro-naphthalene-2-yl)-acetonitrile 
• 948833-69-0 4-{[1-(6-fluoro-naphthalen-2-ylmethyl)-piperidin-4-ylcarbamoyl]-methylsulfanyl}-benzoic acid methyl ester 

Relevant academic research and scientific papers

BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF

Compounds, compositions and methods are provided for modulating the activity of EP2 and EP4 receptors, and for the treatment, prevention and amelioration of one or more symptoms of diseases or disorders related to the activity of EP2 and EP4 receptors. In certain embodiments, the compounds are antagonists of both the EP2 and EP4 receptors.

FUSED HETEROCYCLIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

The present invention is directed to fused heterocyclic compounds of formula (I): which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schi

CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS

The invention relates to novel cyclohexylamine derivatives and their use in the treatment and/or prevention of central nervous system (CNS) disorders, such as depression, anxiety, schizophrenia and sleep disorder as well as methods for their synthesis. The invention also relates to pharmaceutical compositions containing the compounds of the invention, as well as methods of inhibiting reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine from the synaptic cleft and methods of modulating one or more monoamine transporter.

Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF release

Compounds of Formula (1) wherein: R is methyl substituted by one to three groups from alkyl, aryl, alkenyl, and alkynyl; n is ) or 1; R1is arylmethyl or heterocyclylmethyl; R2is alkyl, alkenyl, cycloalkyl or cycloalkenyl; and R3is hydrogen, alkyl, alkenyl, alkynyl or aryl; are useful in the treatment of disorders mediated y s-CD23.

Antihyperglycemic Activity of Novel Naphthalenyl 3H-1,2,3,5-Oxathiadiazole 2-Oxides

A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus.Substitution at the 1-,5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4--3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.

Piperid-4-yl ureas and thio ureas used as antidepressant agents

The invention concerns the preparation of compounds of formula STR1 and acid addition and quaternary ammoniun salts thereof, wherein the dotted line represents an optional bond, Ar represents a ring system of formula STR2 in which Q is O, S, --CR7/s